A clinically studied GLP-1 pathway treatment for appetite control and metabolic health
For an exploration of sub-threshold dosing approaches, our microdosing tirzepatide chart covers the calculations for ultra-low doses
first monthly-or-less-frequent obesity drug in Phase 2
Product Specifications Peptide: FOXO4-DRI (Proxofim) Concentration: 10mg per vial Form: Lyophilized powder Purity: 98% (HPLC Verified) CAS Number: N/A (experimental compound) Molecular Formula: C114H172N32O30 Molecular Weight: ~2651.0 g/mol Shelf Life: 36 months if stored properly Storage & Handling Instructions For laboratory research handling only
Cheng J, Zhang R, Xu Z, Ke Y, Sun R, Yang H, et al
This article provides a factual comparison of BPC-157 and TB-500 across their structure, mechanisms, published research, and why they are often studied together